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Summary 
T cells expressing 3'/8 T cell receptors home to epithelial tissue and may play a role in immunity 
to infectious agents and foreign antigens. In an effort to understand the role of "y/8 T  cells in 
directing B call responses, we investigated the capacity of human 3'/8 T cells to express CD40 
ligand (CD40L) and to drive immunoglobulin (Ig) isotype switching in B cells. A multiple step 
purification procedure resulted in the recovery of highly pure populations of peripheral blood 
CD4-CD8-  3,/8 T cells. Neither CD40L surface expression  nor CD40L mRNA were detected 
in unstimulated 3'/8 T  cells. Stimulation with phorbol ester and ionomycin induced CD40L 
mRNA and surface CD40L expression by 3'/8 T  cells. Both the percentage of CD40L + cells 
and the cell surface density of CD40L were significantly lower in "y/8 T cells compared to unselected 
T  cells. We further demonstrated that in the presence of neutralizing monodonal antibody to 
interferon y  (IFN-y), y//~ T cells could induce IgE synthesis in B cells, albeit to a lesser extent 
than unsdected T  cells.  Furthermore, IgE synthesis driven by 3'/8  T  cells was inhibited by 
monodonal antibody to CD40L. These observations demonstrate that activated ~//8 T cells express 
CD40L and can induce isotype switching in B cells. 
a)//8 
T cells represent a substantial percentage of the lym- 
phocyte population in areas of the body exposed to large 
amounts of foreign antigens, such as the large intestine in 
humans, and the lung, skin, and intestines in mice. This lo- 
calization makes them well suited for the orchestration of 
an early immune response to a variety of pathogens and for- 
eign antigens (1). 
"y/8 T  cells proliferate to Con A,  anti-CD3 mAb, heat 
shock proteins and other bacterial mycobacterial antigen, su- 
perantigen, tetanus toxin, and herpes simplex virus glyco- 
protein I and can recognize both classical and nonclassical 
MHC molecules (1). Little is known about the capacity of 
3~/8 T  cells in directing B cell function. CD4 + "y//$ T cell 
clones have been shown to induce IgM, IgG, and IgA syn- 
thesis by B cells in the presence of IL-2, and IgE synthesis 
in the presence of IL-4, whereas CD4-CD8-  and CD8 + 
clones were ineffective (2, 3). Membrane preparations derived 
from activated CD4 + ",//8 T cells could replace whole cells 
in the induction of Ig synthesis (2, 3). Recently, mice defident 
in ol//~ + T cells were found to make Ig of all isotypes with 
high levels of IgE and IgG1, suggesting a role for q//8 T cells 
in directing isotype switching (4). 
Interaction between the B cell surface antigen CD40 and 
its ligand (CD40L) plays a critical role in T cell-dependent 
isotype switching in vitro (5). CD40L is expressed on acti- 
vated CD4 + T cells with only low level expression on acti- 
vated CD8 + T calls (6), and is also expressed on mast cells 
and basophils.  These cells have been shown to support iso- 
type switching in B cells (7). In this paper, we demonstrate 
that highly purified CD4-CD8-  y/8 T cells isolated from 
normal peripheral blood express CD40L after stimulation with 
PMA and ionomycin and are able to induce isotype switching 
in B cells. 
Materials and Methods 
mAbs.  Anti-CD3, anti-CD4, and anti-CD8 mAbs were purified 
from ascites raised by injecting mice with OKT3, OKT4, and 
OKT8 hybridomas obtained from the American Type Culture Col- 
lection (Rockville, MD). FITC- and PE-conjugated mAbs to TCR- 
c~/B (WT-31), TCR-'y/~, CD3, CD4, CD8, CD14, CD19, and 
CD56 were purchased from Becton Dickinson & Co. (Mountain 
View, CA). The anti-CD40 mAb 626.1 was a gift of Dr. S. M. 
Fu (University of Virginia, Charlottesville, VA). The anti-CD40L 
mAb 5c8 was a generous gift of Drs. S. Lederman and L. Chess 
(Columbia University, New York). 
CelIPo~lations.  Peripheral  blood y/~ T and B calls were purified 
from healthy adult blood donors. Mononuclear cells  were separated 
by FicoU-Hypaque (Pharmacia, Piscataway, NJ) gradient centrifu- 
gation and rosetted with sheep red blood ceils (E) for 2 h. The 
E + cells were suspended at 107 cells/ml in ILPMI 1640 medium 
supplemented with 10% AB + serum (Sigma Chemical Co., St. 
Louis, MO), and adhered overnight on plastic plates at 37~  and 
5% CO2. Monocyte-depleted E § cells were incubated with anti- 
CD4 and anti-CD8 mAbs (1:100 dilution of ascites), washed, rein- 
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Magnetics, Cambridge, MA), and subjected to magnetic separa- 
tion as per the manufacturer's instructions. The negatively sorted 
cells were stained with FITC-conjugated anti-TCR-r  mAb and 
with PE-conjugated anti-TCR-3~/~ mAb and subjected to FACS  | 
(Becton Dickinson & Co.) sorting. The 3"/6 T cells obtained were 
uniformly >97% pure and contained <0.5% c~//~ T cells. E § cells 
isolated after adherence were used as control unselected T cells. 
B cell-enriched populations were prepared as described (8). The 
cell preparation obtained contained <0.5% c~//8 T cells as assessed 
by flow cytometry. 
Cell Surface Expression of CD40.  T cells were stimulated with 
20 ng/ml PMA and 0.5/~M ionomycin  (Calbiochem-Novabiochem 
Corp., San Diego, CA). The cells were then stained with a fusion 
protein constructed from the extracellular domain of CD40 and 
the  Fc  portion  of human  IgG1 (sCD40) or  with  a  control 
CD44:IgG1 fusion protein, both constructs a kind gift of  Dr. Ivan 
Stamenkovic (Massachusetts General Hospital, Boston, MA) fol- 
lowed by FITC-conjugated  goat anti-human Ig (Becton  Dickinson 
& Co.), and analyzed by FACScan  |  (Becton Dickinson & Co.) as 
previously described (9). 
Northern Blot Analysis.  T cells were incubated with PMA and 
ionomycin for 3 h or left unstimulated. Total RNA was extracted 
by the method of Chomczynski and Sacchi (10). 3/~g of RNA 
was fractionated on a 1.5% formaldehyde/agarose  gel, blotted on 
nitrocellulose, and hybridized with random  primer  3zp-labeled 
(Pharmacia) full-length human CD40L eDNA probe (gift of Dr. 
Alessandro Aruffo, Bristol-Myers Squibb, Seattle, WA). 
Cell Culture and IgE Assay.  B cells and autologous irradiated 
(2,500 tad) T cells  were incubated in 12 x 75-ram tubes (1:2 ratio, 
final concentration 1.5  x  106 cells/ml) in RPMI 1640 with 10% 
heat-inactivated FCS (Hyclone Sterile Systems Inc., Logan, UT). 
Cells were cultured at 37~  and 5% COy Ib4 and Ib6 (g & 
D Systems,  Minneapolis,  MN) were added to all cultures at 5 ng/ml 
each. Neutralizing anti-IFN-"/(Genzyme, Cambridge, MA) was 
added at 20 U/ml. Supernatants from cultured cells were collected 
on day 12 of culture, and IgE was measured  by a RIA, with a limit 
of sensitivity of 150 pg/ml. 
Results 
CellPurity.  Using the protocol outlined in Materials and 
Methods, we routinely obtained 3'//~ T cells with >97% pu- 
rity and <0.5% o~/~ T cell contamination as assessed  by two- 
color flow cytometry. A  typical FACS  |  profile of purified 
3'/~ T  cells is presented in Fig.  1.  In  10 experiments, the 
mean purity of y//t T  cells was 98.3  +  0.55%  with 0.19 
-+  0.09% contamination by oe/B T cells. Fig.  1 also shows 
that <0.5% of the purified 3'/6 T cells expressed CD4 and 
<1.5% expressed  CD8.  This is not unexpected given that 
the purification process included negative selection against 
CD4 and CD8 expression. 
B cell preparations contained >70%  CD19 + B cells and 
<0.5%  CD3 + cells. The majority of contaminating cells 
were CD14 + monocytes ("~5%) and CD56 + NK  ('~20- 
25%) cells. More importantly, the B cell preparations failed 
to proliferate  in response  to PHA (data not shown). 
CD40L Expression on 9"/3 T Cells.  It has been shown pre- 
viously that CD40L is expressed on T cells only after activa- 
tion, with peak surface expression 6 h after stimulation with 
PMA  +  ionomycin (9). Fig. 2 compares CD40L expression 
on ~///~ T cells and unselected T cells isolated from the same 
individual. Freshly isolated unstimulated 3'//~ T cells expressed 
no detectable  CD40L as assessed by their capacity to bind 
sCD40 and did not bind the control fusion protein CD44: 
IgG1. Fig. 2 shows that stimulation with PMA +  ionomycin 
induced CD40L expression  on y/fi T cells. This expression 
was vigorous at 6 h and waned by 24 h after stimulation. 
The percentage of CD40L + cells and the surface density of 
CD40L protein, as measured by mean fluorescence intensity 
(MFI) were consistently lower on y//~ T ceils compared to 
unselected T cells derived from the same donor and stimu- 
lated in parallel.  In three experiments, the mean percentage 
of CD40L + cells after 6  h  of stimulation with PMA  + 
ionomycin was 43% for y/b T cells and 81% for unselected 
T cells (p  =  0.012), with average mean fluorescence intensi- 
ties of 81 and 108, respectively (p <0.01). The lower capacity 
of 3'/6 T cells to express CD40L was unlikely to be due to 
prior engagement of the TCR during purification because 
incubation of unselected T  cells with anti-TCR-odt$ mAb 
did not affect their capacity to express CD40L after stimula- 
tion with PMA  +  ionomycin (data not shown). 
We next  compared CD40L  mRNA expression  in y/~ 
T cells and unselected T cells. We have previously shown that 
stimulation of unselected peripheral blood T cells with PMA 
+  ionomycin induces CD40L mRNA expression that peaks 
at 3 h (9). Because of the limited number of highly purified 
3'/6 T cells available, we examined CD40L mRNA expres- 
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Figure  1.  FACS  |  analysis of 
purified  7/~ T cells. Purified  periph- 
eral blood  3'/~ T cells  (see  Materials 
and Methods)  were stained  with  PE- 
conjugated  anti-TCIL-~'/~  and with 
FITC-conjugated anti-TCR-c~/~8 
mAb (A), FITC-conjugated  anti- 
CD4 (B), or FITC-conjugated  anti- 
CD8 (C). The data were analyzed 
using Consort  30 software  (Becton 
Dickinson  &  Co.). Numerical  values 
describe the percentage  of  cells  con- 
tained in each quadrant. The data 
shown are representative  of multiple 
experiments. 
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Figure  2.  CD40L  expression  on 
￿9  '//~ T  cells. 7/c5 T cells and un- 
selected  T cells  from  the same  donor 
were either left unstimulated or 
were stimulated in parallel with 
PMA (20 ng/ml) and ionomycin 
(0.5 gM). At the indicated  times, 
cells  were  harvested  and stained  with 
sCD40 (see  Materials  and Methods). 
sCD44 was used as a control for 
nonspecific  staining.  The data  were 
analyzed using LYSYS software 
(Becton Dickinson & Co.), and 
regions were set to exclude 95% 
of the cells staining with sCD44. 
The percent CD40L  + cells,  and the 
mean fluorescence  intensity  for the 
region are given  in the upper right 
hand  comer  of each  histogram.  The 
data shown are representative of 
three experiments. 
sion at this time point. Fig. 3 shows a Northern blot analysis 
for CD40L mRNA in 3'/8 T  cells and unselected T  cells 
from  the  same  donor  stimulated in  parallel.  No  CD40L 
mRNA was detected in either cell population at rest. 3 h 
after stimulation with PMA +  ionomycin, CD40L mRNA 
was expressed by both cell populations, however the level of 
CD40L mRNA was much lower in ~/8 T  cells compared 
to unselected T  cells. Taken together, these results indicate 
that 3'/8 T  cells are able to express CD40L, but to a lesser 
degree than unselected T  cells. 
IgE Synthesis in Cultures of B Cells and'y/~  T  Cells.  Given 
the capacity of'y/8 T ceils to express CD40L, we next exam- 
ined their ability to help autologous B cells undergo IgE iso- 
type switching in vitro. Irradiated T  ceils were mixed with 
B cells at a ratio of 2:1 and the cells were cultured for 12 d 
in the presence of IL-4 (5 ng/ml) and IL-6 (5 ng/ml) to op- 
timize IgE production. Under these conditions, unselected 
T  ceils consistently induced IgE synthesis, whereas 3,/8 T 
cells failed to do so (data not shown, n  =  3 experiments). 
Moreover, no IgE synthesis could be detected at ratios of 7/8 
T cells to B ceils ranging from 0.5:1 to 4:1 (data not shown). 
The failure of 3,/8 T cells to induce isotype switching under 
Figure 3.  CD40L  mRNA  expres- 
sion by 3'/8 T cells. T cells were in- 
cubated with PMA (20 ng/ml) and 
ionomycin (0.5 gM) for 3 h or left 
unstimulated.  Northern  blot analysis 
was performed  using  a human  CD40L 
cDNA probe (top). Ethidium  bromide 
staining of 28S and 18S RNA illus- 
trates the relative  amounts  of RNA 
loaded in each lane (bottom). 
these culture conditions was unlikely due to prior engage- 
ment of their antigen receptor by mAb during purification 
because incubation of unselected T cells with anti-TCR-odfl 
mAb did not diminish their capacity to induce isotype switch- 
ing. More importantly, 7/8 T  cells purified by negative se- 
lection from CD4-CD8-  T  cell populations without 7/8 
TCR engagement were unable to drive isotype switching 
(data not shown). 
T  cell dependent IgE synthesis is sensitive  to inhibition 
by IFN-3, (11). It has been previously reported that human 
7/8  T  cell  clones secrete  higher (four-  to  fivefold  more) 
amounts of IFN-3, than ot/fl T cell clones (12). We therefore 
examined the capacity of 3'/8 T cells to induce IgE synthesis 
in B cells cultured with IL-4 and IL-6, in the presence  of 
neutralizing mAb to IFN-7. Table 1 shows that in the pres- 
ence of neutralizing IFN-7 mAb, both 3'/8 T  cells and un- 
selected T  cells induced substantial IgE synthesis in B cells, 
but that B cells by themselves produced little or no IgE. This 
was unlikely to be due to cr  T cell contamination because 
our preparations of 3'/8 T  and B cells uniformly contained 
<0.5% ot/fl  T  cells. To further prove that IgE synthesis in 
cultures of 3'/8 T and B cells was not due to contaminating 
ot/fl  T  cells, we cultured B cells with increasing numbers 
of unselected T cells. No IgE synthesis could be detected in 
the presence of up to 5 % unselected T cells (data not shown). 
In another approach, we examined cultures containing 7/8 
T  and B cells for their content of ot/fl  T ceils at the begin- 
ning and at the end of the 12-d culture period, and detected 
no increase in the percentage of contaminating ol/fl T  cells 
(data not shown). 
Induction of IgE synthesis by 3'/8 T cells was consistently 
and significantly less than for unselected cells. In three ex- 
periments, the mean IgE synthesis induced by 3'/8 T  cells 
was 2,994  _+  1,476 pg/ml versus 17,560  +  7,363 pg/ml in- 
duced by unselected T  cells (p <0.03).  We considered the 
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IgE 
T cells  IL-4  Exp 1  Exp 2  Exp 3 
pg/ml 
-  -  <150  <150  <150 
-  +  349  +  24  <150  259  +  6 
7/8  -  <150  <150  <150 
",//8  +  3,149  +  510  1,446  _+ 44  4,386  +  310 
Unselected  -  <150  <150  <150 
Unselected  +  23,972  _+  1,256  9,519  _+ 543  19,189  •  440 
T  cells were irradiated with 2,500 rad and added to autologous B cells at  a ratio of 2:1.  IL-4 was added at  5  ng/ml.  All cultures received IL-6 
(5 ng/ml) and neutralizing anti-IFN-y mAb (40 U/ml). Supernatants were harvested on day 12,  and IgE content was measured by RIA. Samples 
were run in duplicate and the results are expressed as mean  _+  SD. 
possibility that the lower capacity of 3,/8 T  cells to induce 
IgE synthesis was due to incomplete neutralization of IFN-3/, 
however, increasing  the concentration  of anti-IFN-3, mAb 
up to 1,000 U/m1 did not result in increased in IgE synthesis 
(data not shown). Furthermore, we compared IFN-3/produc- 
tion by 3//6 T  cells and unselected T  cells after stimulation 
with PMA  +  ionomycin or with insolubilized anti-CD3 and 
after a 12-d incubation with B cells and IL-4 +  IL-6 to mimic 
the conditions used in the IgE assay. Under all these condi- 
tions, 3//6 T ceUs and unselected T cells produced equivalent 
amounts of IFN-3/(data not shown). We also considered the 
possibility that 3//8 T ceils may express cell-associated mole- 
cules or cytokines other than IFN-3/which exert an inhibi- 
tory effect on IgE production.  Addition  of 3//8 T  cells at 
a 2:1 ratio to B cells cultured with anti-CD40 mAb (5 #g/m1) 
and IL-4 (5 ng/ml) did not inhibit IgE synthesis. These ob- 
servations suggest that the lower capacity of 3//6 T  cells in 
inducing IgE synthesis is unlikely to be due to excessive produc- 
Table  2.  Antibody to CD40L Inhibits Induction of 
IgE Synthesis by 7/~ T cells 
IgE 
T cells  IL-4  mAb  Exp  1  Exp 2 
pg/ml 
-  -  -  <150  578 
-  +  -  <150  575 
+  +  -  21,250  5,653 
+  +  5C8  191  <150 
+  +  IgG2a  22,328  9,126 
Culture conditions were as described in Table 1. mAbs were used at 10 
/~g/ml. 
tion of IFN-y or to an inhibitory effect of these cells on IgE 
production. 
To ascertain the role of CD40L-CD40 interactions in the 
induction of IgE synthesis by 3'/6 T  cells, we examined the 
effect of the anti-CD40L mAb 5c8 in this system. Table 2 
shows  that  addition  of 5c8  mAb  (10  /~g/ml)  completely 
abrogated 3//6 T  cells driven IgE synthesis in IL-4 treated 
B cells.  These results indicate a functional role for CD40L 
expressed on 3//8 T  cells. 
Discussion 
In  this  paper  we demonstrate  that  3//6  T  cells  express 
CD40L after activation and are able to induce isotype switching 
in B cells. 
We have used a multiple step purification procedure that 
yielded highly pure populations of 3//6 T cells ().97% pure) 
with <0.5% contamination by o#fl T cells (Fig.  1). We used 
double negative 3'/6 T cells because positive selection of 3//6 
T cells is extremely difficult given their low percentage. We 
had first to enrich E + cells for 3//6 T cells by depleting c~/fl 
T  cells.  We did  this  by negative  selection  of CD4 +  and 
CD8 + cells rather than by negative selection of a/fl T cells 
because the hybridoma needed to generate suf~dent anti-TCR- 
a/fl mAb was not available. Freshly isolated y/6 T cells ex- 
pressed neither CD40L on their surface nor CD40L mRNA. 
Stimulation  with  PMA  +  ionomycin for 6  h  resulted  in 
CD40L surface expression.  Both the percentage of CD40L + 
cells and intensity of CD40L surface expression were lower 
for 3//6 T cells than for unselected T cells (Hg. 2). This differ- 
ence is not likely to be due to different kinetics of CD40L 
expression in 3//6 T  cells because it was seen both at 6 and 
24 h  after stimulation  with PMA  +  ionomycin,  nor was 
it likely to be due to engagement of the 3'/6 T  cell antigen 
receptor by mAb during purification,  as such engagement 
did not effect CD40L expression on unselected T cells. IFN-y 
has been reported to inhibit  CD40L expression on murine 
1242  CD40L  Expression and Function in qr/~ T  Cells T cells (13), but addition of neutralizing mAb to IFN-3' did 
not  enhance  CD40L  expression on 3'//$  T  calls  (data  not 
shown).  However we cannot  rule out the possibility that 
cytokines other than IFN-3" may have played a role in down- 
regulating  CD40L expression by 3'//$  T  cells. 
The lower surface expression of CD40L on 3///$ T  ceils 
was accompanied by lower level CD40L mKNA expression 
compared to unselected T  cells. This lower expression may 
be due to a lower rate of transcription  or to a higher rate 
of mRNA degradation in 3'//$ T  cells.  The 3' untranslated 
CD40L mRNA contains AUUUA sequences (14) which are 
known to confer instability to cytokine mRNAs (15). Run 
on assays and measurements of mRNA half life will help clarify 
the mechanisms responsible for the decreased expression of 
CD40L by 3'/8  T  cells. 
CD40L expressed on 3'//$ T  ceUs was biologically active 
because 3'//$  T  cells were able to induce isotype switching 
to IgE in B cells  (Table 1) and this was inhibited by anti- 
CD40L mAb (Table 2). Even with the addition of neutralizing 
mAb to IFN-3', 3'/8 T cells induced significantly lower IgE 
production  than  unselected T  cells.  Previous reports  have 
shown that  CD4-CD8-  3'//$  T  cell clones secrete higher 
levels of IFN-3' than ol//3 T cell clones (12). In our studies, 
however, IFN-3' production was equivalent for freshly iso- 
lated y//$ and unselected T  cells, suggesting that the lower 
capacity of 3"//$ T  cells to drive IgE synthesis was not due 
to their overproduction of IFNw. We have previously reported 
that interaction between CD4 and MHC class II molecules 
is important for T cell-dependent isotype switching (16). Ab- 
sence of CD4 expression in our 3'//$ T cell preparations also 
may have contributed to their lower capacity to induce iso- 
type switching. It has been previously suggested that the den- 
sity of CD40L expression on the surface ofT cells determines 
their capacity to activate B cells (6).  The lower capacity of 
3'//$ T cells to express CD40L and to induce isotype switching 
is consistent  with  this notion. 
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